MYBPC3 and cardiac hypertrophy: Previous studies have shown that, in most cases, HCM with MYBPC3 gene mutations is a late onset disorder with mild myocardial hypertrophy, a lower rate of sudden cardiac death, and relatively benign disease progression [25, 26].